Biotech and Tech Stocks Surge in Small-Cap Rally
By ATTN Desk · Editorial oversight: Sean Han
Daily Market Recap – 2025-06-25
On June 25, 2025, U.S. equity markets saw pronounced activity among small- and micro-cap names, particularly in the biotech and technology sectors. A slew of stocks recorded double-digit percentage gains, driven by clinical updates, strategic announcements and heightened trading volumes. Below is a summary of key movers, overall trends and notable volume surges from today’s session.
Key Stock Data
| Ticker | ATTN Price | Current Price | Volume | Price Change % |
|---|---|---|---|---|
| PSTV | 0.3420 | 0.3420 | 448,249,689 | 52.63% |
| SONM | 1.2301 | 1.2301 | 46,673,020 | 50.86% |
| GCTK | 7.6100 | 7.6100 | 14,374,772 | 110.04% |
| ULY | 8.6800 | 8.6800 | 13,957,068 | 40.60% |
| INDP | 0.3599 | 0.3599 | 1,668,309 | 14.71% |
| QS | 5.6800 | 5.6800 | 112,809,292 | 19.59% |
| SRFM | 2.5999 | 2.5999 | 60,017,282 | 139.06% |
| LFWD | 0.6146 | 0.6146 | 9,281,367 | 39.72% |
| XTIA | 1.7000 | 1.7000 | 9,424,980 | 29.17% |
| RBNE | 3.6800 | 3.6800 | 3,471,996 | 46.67% |
| CETX | 1.0400 | 1.0400 | 6,808,773 | 43.80% |
| ICU | 0.4930 | 0.4930 | 184,101,125 | 86.36% |
| CREV | 3.0000 | 3.0000 | 2,138,516 | 38.64% |
| NKTR | 29.1107 | 29.1107 | 19,563,334 | 60.22% |
| NNNN | 31.8500 | 31.8500 | 412,907 | 60.66% |
| XBIO | 3.8800 | 3.8800 | 1,549,801 | 81.42% |
| CURV | 3.1800 | 3.1800 | 4,611,759 | 9.94% |
| FTRK | 1.7500 | 1.7500 | 5,555,757 | 97.76% |
| VYNE | 1.4300 | 1.4300 | 5,889,401 | 47.22% |
| FMFC | 4.4000 | 4.4000 | 2,533,687 | 50.71% |
Market Trends and Patterns
Today’s session was characterized by exceptional volatility among lower-priced equities. Biotech and medical device stocks led the charge after a wave of clinical trial updates and regulatory filings:
- Major percentage gains were concentrated in sub-$10 issues, underscoring investor appetite for high-beta plays.
- Seven names eclipsed 50% gains, with SRFM (+139%) and GCTK (+110%) posting the day’s largest moves.
- Average volume in this group ran well above long-term averages, particularly for ICU (184 million shares) and PSTV (448 million).
Momentum and rotation played key roles: as one stock hit new highs, capital swiftly redeployed into the next catalyst-driven opportunity. Overall breadth was positive, though the spotlight remained on small caps rather than the broader market’s blue-chip components.
Notable Movers and Volume Surges
Several names stood out for both price action and trading activity:
- SRFM (+139.06%): Surf Air Mobility surged after announcing strategic partnerships in electrified aviation and securing new AI-driven analytics contracts.
- GCTK (+110.04%): Glucotrack rallied on news of an FDA IDE submission for its continuous glucose monitoring implantable system.
- FTRK (+97.76%): Fast Track Group jumped following strong reception to its recent IPO and plans for Southeast Asian venue expansions.
- ICU (+86.36%): SeaStar Medical advanced with multi-hospital commitments for its QUELIMMUNE device in acute kidney injury trials.
- XBIO (+81.42%): Xenetic Biosciences climbed on updates to its DNase oncology combination trials and new licensing agreements.
On the volume front, PSTV (448 million), ICU (184 million) and QS (113 million) were among the busiest, reflecting speculative trading and high-frequency activity.
tl;dr
- Small-cap and micro-cap names dominated today’s gains, led by biotech and aviation-technology stocks.
- SRFM, GCTK and FTRK each nearly doubled or more on strategic and regulatory catalysts.
- Exceptional volume spikes in PSTV, ICU and QS highlight the session’s high-beta environment.
- Overall market breadth remained positive, driven by rotation into news-driven, high-volatility issues.